wateroperator wrote: As investors took the summer to enjoy family, friends, and anything but the stock market, capital dried up, and the age old saying “Sell in May & Go Away” could not have been more true. Last year, Cannabis stocks picked up heavily in July, and rallied straight until earlier this year with the Federal Government’s announcement detailing the legal framework of the Cannabis Act, in April. This year, has been a little different. We saw a glimmer of hope in July the same week things started moving last year, but that unfortunately, was all it was.
The amount of hype built up prior to this April date combined with your standard summer selling, lines up almost perfectly with our predictions. In case you missed it our 10 predictions for 2017 article was published in December 2016, and sent to our database of subscribers. We will outline it again for you here, our first three predictions:
1) Cannabis legislation will be introduced in Spring 2017, detailing the legalization of Cannabis across Canada. This legislation will include instructions from the Government on how the implementation of recreational marijuana will take place. Cannabis Legalization will maintain the existing framework and e-commerce platform that’s been in existence since 2013 with the med market.
2) Marijuana stocks will rally and move higher from January 2017 - to April 2017, then taper off moving into the summer. There will be a 6-month quiet period, or a waiting period from April/May 2017 - October/November 2017, as short sighted investors take profits.
3) This will be the most incredible buying opportunity of our lifetime - an entire industry deregulating right in front of us. From October to December, the market will start to pick up again in anticipation of federally legal recreational marijuana market coming in 6 months, first being introduced in Spring of 2018.
This was taken verbatim from our article, and we seem to be on a pretty good track.
We’re in the middle of what we predicted 9 months ago, the “6-month quiet period, or a waiting period from April/May 2017 - October/November 2017” which will present “the most incredible buying opportunity of our lifetime” which is exactly why we are choosing this time to bring the newsletter back to life.
That is the opportunity. And that is why we want to start talking again at this time.
The amount of undervalued cannabis stocks on the market right now is incredible. Companies like Emblem who hit $4.62 in December last year are now trading well under $2.00. Canopy, who hit a high of $19 in November, is now floating around the $10.00 mark, up nicely from the lows of around $6.75 in July. MedReleaf, a recent addition to the market has crept right back up to its IPO price. The whole cannabis market took a large step higher, no pun intended, on the 6th of September. These are the initial signs of investors coming back from their vacations, and picking up undervalued plays.